Radioactive Drug Research Committee (RDRC) Report on Research Use of Radioactive Drug Study Summary

⚠️ Notice: This information collection may be referencing outdated material. More recent filings for OMB 0910-0053 can be found here:

Documents and Forms

Document Name Document Type
Form FDA 2915 Radioactive Drug Research Committee (RDRC) Report on Research Use of Radioactive Drug Study Summary Form
FDA 2915 Study Summary FDA-2915.doc Form

Information Collection (IC) Details

View Information Collection (IC)

IC Title:	Radioactive Drug Research Committee (RDRC) Report on Research Use of Radioactive Drug Study Summary	Agency IC Tracking Number:

Is this a Common Form? Yes		IC Status: New

Obligation to Respond: Mandatory

CFR Citation: 21 CFR 361.1(c)(2)

Information Collection Instruments:

Document Type	Form No.	Form Name	Instrument File	URL	Available Electronically?	Can Be Submitted Electronically?	Electronic Capability
Form	FDA 2915	Study Summary	FDA-2915.doc		No	No	Paper Only

Line of Business: Health

Subfunction: Illness Prevention

Privacy Act System of Records
Title:	FR Citation:

Number of Respondents: 80	Number of Respondents for Small Entity: 0

Affected Public: Private Sector	Private Sector: Businesses or other for-profits

Percentage of Respondents Reporting Electronically: 0 %

	Approved	Change Due to Adjustment in Agency Estimate
Annual Number of Responses for this IC	320	320
Annual IC Time Burden (Hours)	3,200	3,200
Annual IC Cost Burden (Dollars)	0	0

Documents for IC

Title	Document	Date Uploaded
No associated records found

Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.